66 related articles for article (PubMed ID: 37951919)
1. A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma.
Wang X; Huang S; Li X; Jiang D; Yu H; Wu Q; Gao C; Wu Z
PLoS One; 2018; 13(7):e0200290. PubMed ID: 30005075
[TBL] [Abstract][Full Text] [Related]
2. [Bioinformatic analysis of CCND2 expression in papillary thyroid carcinoma and its impact on immune infiltration].
Wang Q; Song B; Hao S; Xiao Z; Jin L; Zheng T; Chai F
Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):981-988. PubMed ID: 38862457
[TBL] [Abstract][Full Text] [Related]
3. Homogentisic acid metabolism inhibits papillary thyroid carcinoma proliferation through ROS and p21-induced cell cycle arrest.
Xie R; Lin J; Li W; Chen H; Zhang J; Zhong M; Xue J; Mo C; Chen L; Zhu Y; Chen X; Xu S
Life Sci; 2024 Jun; 347():122682. PubMed ID: 38702025
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic utility of TROP-2, SLP-2, and CXCL12 expression in papillary thyroid carcinoma.
Attia AS; Hussein S; Sameh H; Khalil A; Waley AB; Matar I; Sameh R
Cancer Biomark; 2024; 39(3):211-221. PubMed ID: 38073379
[TBL] [Abstract][Full Text] [Related]
5. A diagnostic model based on DNA methylation haplotype block characteristics for identifying papillary thyroid carcinoma from thyroid adenoma.
Xu D; Lai Y; Liu H; Li H; Feng N; Liu Y; Gong C; Zhang Y; Zhou J; Shen Y
Transl Res; 2024 Feb; 264():76-84. PubMed ID: 37863284
[TBL] [Abstract][Full Text] [Related]
6. The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis.
Gulcelik NE; Akin S; Aydin K; Aydin Mericoz C; Guler Tezel YG; Usman A
Minerva Endocrinol (Torino); 2023 Dec; 48(4):379-386. PubMed ID: 35775885
[TBL] [Abstract][Full Text] [Related]
7. The association between serum selenium levels and pathological features of papillary thyroid cancer in 284 patients.
Ge S; Zhao J; Yao J; Fu H; Tian Y; Shan Y; Sun M; Feng J; Dong J; Liao L
Front Endocrinol (Lausanne); 2023; 14():1242250. PubMed ID: 38027150
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Profiles and Blood Biomarkers to Discriminate between Benign Thyroid Nodules and Papillary Carcinoma, Based on UHPLC-QTOF-ESI
Berinde GM; Socaciu AI; Socaciu MA; Petre GE; Socaciu C; Piciu D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542465
[TBL] [Abstract][Full Text] [Related]
9. Stimulated Raman Scattering Microscopy Reveals Aberrant Triglyceride Accumulation in Lymphatic Metastasis of Papillary Thyroid Carcinoma.
Zeng J; Wu G; Jia H; Liu C; Liu C; Zhang Y; Liu S; Wang J; Yue S
Anal Chem; 2024 Apr; 96(15):5735-5740. PubMed ID: 38567982
[TBL] [Abstract][Full Text] [Related]
10. Expression of serum AMPD1 in thyroid carcinoma and its clinical significance.
Zha T; Wu H
Exp Ther Med; 2018 Apr; 15(4):3357-3361. PubMed ID: 29545855
[TBL] [Abstract][Full Text] [Related]
11. Exploring the clinical utility of angioinvasion markers in papillary thyroid cancer: a literature review.
Buczyńska A; Kościuszko M; Krętowski AJ; Popławska-Kita A
Front Endocrinol (Lausanne); 2023; 14():1261860. PubMed ID: 38089632
[TBL] [Abstract][Full Text] [Related]
12. A case of papillary hyperplasia of thyroid misdiagnosed as papillary thyroid carcinoma: Case report and review of literature.
Alharbi SF; Abba AA; Hafiz AA; Abdulhalim AM; Bokhari GY; Esheba GE
Clin Case Rep; 2021 Nov; 9(11):e04867. PubMed ID: 34765196
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological implications of leptin and leptin receptor expression in papillary thyroid cancer.
Zhang GA; Hou S; Han S; Zhou J; Wang X; Cui W
Oncol Lett; 2013 Mar; 5(3):797-800. PubMed ID: 23425972
[TBL] [Abstract][Full Text] [Related]
14. 'Miliary metastasis' in a child with papillary thyroid cancer.
Gie A; Schubert P; Conradie W; Goussard P
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35672061
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Intrathyroid Tissue: a Report of Intrathyroid Lymph Node Metastasis and a Review of Literature.
Shawky MS; Meyer-Rochow W
Indian J Surg; 2017 Apr; 79(2):148-152. PubMed ID: 28442842
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer Via a Biomarker Panel Involving TAC, 8-OHdG, and Sortilin.
Buczyńska A; Kościuszko M; Sidorkiewicz I; Wiatr AA; Adamska A; Siewko K; Dzięcioł J; Szelachowska M; Krętowski AJ; Popławska-Kita A
J Clin Endocrinol Metab; 2024 Jun; 109(7):1866-1872. PubMed ID: 38181425
[TBL] [Abstract][Full Text] [Related]
17. Double Digest: A Rare Case Report of Amphicrine Gastric Carcinoma Co-occurring With Papillary Thyroid Carcinoma.
Ebedes DM; Ganam S; Sujka JA; DuCoin CG
Cureus; 2024 Apr; 16(4):e59205. PubMed ID: 38807830
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma.
Wang CC; Lu DD; Shen MH; Chen RL; Zhang ZH; Lv JH
Diagn Pathol; 2023 Nov; 18(1):123. PubMed ID: 37951919
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.
Lamba Saini M; Weynand B; Rahier J; Mourad M; Hamoir M; Marbaix E
Diagn Pathol; 2015 Apr; 10():32. PubMed ID: 25907675
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
